[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Drug-Eluting Balloon Market Report 2016

November 2016 | 104 pages | ID: UBAFF283048EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Drug-Eluting Balloon

Revenue, means the sales value of Drug-Eluting Balloon

This report studies sales (consumption) of Drug-Eluting Balloon in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Medtronic
  • Boston Scientific
  • Cook Medical
  • C.R. Bard
  • B. Braun
  • Eurocor GmbH
  • Blue Medical
  • Bayer
  • Aachen Resonance
  • Acrostak
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Drug-Eluting Balloon in each application, can be divided into
  • Treatment of In-stent Restenosis (ISR)
  • Treatment of Small Vessel Disease (SVD)
  • Treatment of Bifurcation Stenoses
  • For de-novo coronary artery disease
United States Drug-Eluting Balloon Market Report 2016

1 DRUG-ELUTING BALLOON OVERVIEW

1.1 Product Overview and Scope of Drug-Eluting Balloon
1.2 Classification of Drug-Eluting Balloon
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Drug-Eluting Balloon
  1.3.1 Treatment of In-stent Restenosis (ISR)
  1.3.2 Treatment of Small Vessel Disease (SVD)
  1.3.3 Treatment of Bifurcation Stenoses
  1.3.4 For de-novo coronary artery disease
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drug-Eluting Balloon (2011-2021)
  1.4.1 United States Drug-Eluting Balloon Sales and Growth Rate (2011-2021)
  1.4.2 United States Drug-Eluting Balloon Revenue and Growth Rate (2011-2021)

2 UNITED STATES DRUG-ELUTING BALLOON COMPETITION BY MANUFACTURERS

2.1 United States Drug-Eluting Balloon Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drug-Eluting Balloon Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drug-Eluting Balloon Average Price by Manufactures (2015 and 2016)
2.4 Drug-Eluting Balloon Market Competitive Situation and Trends
  2.4.1 Drug-Eluting Balloon Market Concentration Rate
  2.4.2 Drug-Eluting Balloon Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRUG-ELUTING BALLOON SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Drug-Eluting Balloon Sales and Market Share by Type (2011-2016)
3.2 United States Drug-Eluting Balloon Revenue and Market Share by Type (2011-2016)
3.3 United States Drug-Eluting Balloon Price by Type (2011-2016)
3.4 United States Drug-Eluting Balloon Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DRUG-ELUTING BALLOON SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Drug-Eluting Balloon Sales and Market Share by Application (2011-2016)
4.2 United States Drug-Eluting Balloon Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DRUG-ELUTING BALLOON MANUFACTURERS PROFILES/ANALYSIS

5.1 Medtronic
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Medtronic Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Boston Scientific
  5.2.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Boston Scientific Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Cook Medical
  5.3.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Cook Medical Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 C.R. Bard
  5.4.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 C.R. Bard Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 B. Braun
  5.5.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 B. Braun Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Eurocor GmbH
  5.6.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Eurocor GmbH Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Blue Medical
  5.7.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Blue Medical Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bayer
  5.8.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bayer Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Aachen Resonance
  5.9.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Aachen Resonance Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Acrostak
  5.10.2 Drug-Eluting Balloon Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Acrostak Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 DRUG-ELUTING BALLOON MANUFACTURING COST ANALYSIS

6.1 Drug-Eluting Balloon Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Drug-Eluting Balloon

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Drug-Eluting Balloon Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Drug-Eluting Balloon Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DRUG-ELUTING BALLOON MARKET FORECAST (2016-2021)

10.1 United States Drug-Eluting Balloon Sales, Revenue Forecast (2016-2021)
10.2 United States Drug-Eluting Balloon Sales Forecast by Type (2016-2021)
10.3 United States Drug-Eluting Balloon Sales Forecast by Application (2016-2021)
10.4 Drug-Eluting Balloon Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Drug-Eluting Balloon
Table Classification of Drug-Eluting Balloon
Figure United States Sales Market Share of Drug-Eluting Balloon by Type in 2015
Table Application of Drug-Eluting Balloon
Figure United States Sales Market Share of Drug-Eluting Balloon by Application in 2015
Figure Treatment of In-stent Restenosis (ISR) Examples
Figure Treatment of Small Vessel Disease (SVD) Examples
Figure Treatment of Bifurcation Stenoses Examples
Figure For de-novo coronary artery disease Examples
Figure United States Drug-Eluting Balloon Sales and Growth Rate (2011-2021)
Figure United States Drug-Eluting Balloon Revenue and Growth Rate (2011-2021)
Table United States Drug-Eluting Balloon Sales of Key Manufacturers (2015 and 2016)
Table United States Drug-Eluting Balloon Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drug-Eluting Balloon Sales Share by Manufacturers
Figure 2016 Drug-Eluting Balloon Sales Share by Manufacturers
Table United States Drug-Eluting Balloon Revenue by Manufacturers (2015 and 2016)
Table United States Drug-Eluting Balloon Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drug-Eluting Balloon Revenue Share by Manufacturers
Table 2016 United States Drug-Eluting Balloon Revenue Share by Manufacturers
Table United States Market Drug-Eluting Balloon Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drug-Eluting Balloon Average Price of Key Manufacturers in 2015
Figure Drug-Eluting Balloon Market Share of Top 3 Manufacturers
Figure Drug-Eluting Balloon Market Share of Top 5 Manufacturers
Table United States Drug-Eluting Balloon Sales by Type (2011-2016)
Table United States Drug-Eluting Balloon Sales Share by Type (2011-2016)
Figure United States Drug-Eluting Balloon Sales Market Share by Type in 2015
Table United States Drug-Eluting Balloon Revenue and Market Share by Type (2011-2016)
Table United States Drug-Eluting Balloon Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drug-Eluting Balloon by Type (2011-2016)
Table United States Drug-Eluting Balloon Price by Type (2011-2016)
Figure United States Drug-Eluting Balloon Sales Growth Rate by Type (2011-2016)
Table United States Drug-Eluting Balloon Sales by Application (2011-2016)
Table United States Drug-Eluting Balloon Sales Market Share by Application (2011-2016)
Figure United States Drug-Eluting Balloon Sales Market Share by Application in 2015
Table United States Drug-Eluting Balloon Sales Growth Rate by Application (2011-2016)
Figure United States Drug-Eluting Balloon Sales Growth Rate by Application (2011-2016)
Table Medtronic Basic Information List
Table Medtronic Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medtronic Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Boston Scientific Basic Information List
Table Boston Scientific Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Cook Medical Basic Information List
Table Cook Medical Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cook Medical Drug-Eluting Balloon Sales Market Share (2011-2016)
Table C.R. Bard Basic Information List
Table C.R. Bard Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table C.R. Bard Drug-Eluting Balloon Sales Market Share (2011-2016)
Table B. Braun Basic Information List
Table B. Braun Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table B. Braun Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Eurocor GmbH Basic Information List
Table Eurocor GmbH Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eurocor GmbH Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Blue Medical Basic Information List
Table Blue Medical Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Blue Medical Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Aachen Resonance Basic Information List
Table Aachen Resonance Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aachen Resonance Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Acrostak Basic Information List
Table Acrostak Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acrostak Drug-Eluting Balloon Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Balloon
Figure Manufacturing Process Analysis of Drug-Eluting Balloon
Figure Drug-Eluting Balloon Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Balloon Major Manufacturers in 2015
Table Major Buyers of Drug-Eluting Balloon
Table Distributors/Traders List
Figure United States Drug-Eluting Balloon Production and Growth Rate Forecast (2016-2021)
Figure United States Drug-Eluting Balloon Revenue and Growth Rate Forecast (2016-2021)
Table United States Drug-Eluting Balloon Production Forecast by Type (2016-2021)
Table United States Drug-Eluting Balloon Consumption Forecast by Application (2016-2021)


More Publications